NCT06368102View on ClinicalTrials.gov

Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Surgical Site Infection
Interventions
DRUG

Ampicillin

Total 2g vs 3g

Trial Locations (1)

Unknown

Uji Takeda Hospital, Uji

All Listed Sponsors
lead

Uji Takeda Hospital

OTHER

NCT06368102 - Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery | Biotech Hunter | Biotech Hunter